Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CASR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFYC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKZF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST8SIA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP57L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGSF9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FER1L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TSC22D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4K4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATF6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CT62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCYT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX56 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIRT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SBF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on